Soft Tissue Sarcoma Adult: Clinical Trials

27 trials for Soft Tissue Sarcoma Adult, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 recruiting, 7 completed, 4 active not recruiting, 3 terminated. 10 Phase 2, 6 Not applicable, 6 Phase 1, 2 Early Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 210Recruiting 6, Completed 3, Withdrawn 1
Not applicable6Active not recruiting 3, Completed 1, Recruiting 1, Unknown 1
Phase 16Completed 2, Active not recruiting 1, Recruiting 1, Terminated 1, Withdrawn 1
Early Phase 12Completed 1, Recruiting 1
Phase 31Terminated 1
Phase 41Terminated 1

Follow Soft Tissue Sarcoma Adult: new trials by email Literature Review of Soft Tissue Sarcoma Adult trials Research Report on Soft Tissue Sarcoma Adult

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Assessment of the Long-term Efficacy of Moderately Hypofractionated Neoadjuvant Radiotherapy Soft Tissue Sarcoma in the Limbs or Trunk Wall
Moderately hypofractionated neoadjuvant radiotherapy - Soft Tissue Sarcoma Adult, Soft Tissue Sarcoma (Excluding GIST)
Phase 2RecruitingCentre Oscar Lambret1352026-07-212026-07-23
Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma.
Definitive radiotherapy - Soft Tissue Sarcoma (STS), Soft Tissue Sarcoma Adult
Phase 2RecruitingOslo University Hospital402026-01-262026-01-28
Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma
preoperative, Quality of life, Functional outcome - Soft Tissue Sarcoma (Excluding GIST), Soft Tissue Sarcoma Adult
Phase 2RecruitingOslo University Hospital1102026-01-262026-01-28
A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors
PBA-0111 - Head and Neck Squamous Cell Carcinoma, Soft Tissue Sarcoma Adult
Early Phase 1RecruitingPure Biologics S.A.122025-03-272025-08-11
Fluorescent Aided Resection and Evaluation of Soft Tissue Sarcomas (FLARES)
Aminolevulinic Acid - Soft Tissue Sarcoma, Soft Tissue Sarcoma Adult
Phase 1WithdrawnUniversity of California, Davis2024-07-012024-08-15
A Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors
PBA-0405 - Head and Neck Squamous Cell Carcinoma, Soft Tissue Sarcoma Adult
Early Phase 1CompletedPure Biologics S.A.82024-04-292025-08-11
A Study of Surufatinib in the Treatment of Advanced Soft Tissue Sarcoma
Surufatinib - Soft Tissue Sarcoma Adult
Not applicableUnknownFudan University292023-11-282023-10-31
Sarcomas and DDR-Inhibition; a Combined Modality Study
AZD1390 + radiotherapy, AZD1390 + durvlaumab + radiotherapy - Soft Tissue Sarcoma Adult
Phase 1TerminatedThe Netherlands Cancer Institute122022-07-182026-01-23
Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas
Association of pembrolizumab + cabozantinib - Soft Tissue Sarcoma Adult, Advanced Soft-tissue Sarcoma
Phase 2RecruitingInstitut Bergonié1192022-04-252025-10-07
Phase 1 Study of SON-1010 in Adult Patients With Advanced Solid Tumors
SON-1010 - Advanced Solid Tumor, Soft Tissue Sarcoma Adult
Phase 1Active not recruitingSonnet BioTherapeutics422022-04-202026-02-03
Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients
Observational Translational Study - Sarcoma, Sarcoma, Leiomyo-, Adult
RecruitingRoyal Marsden NHS Foundation Trust8002021-11-192026-02-25
Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients
Propranolol, Pembrolizumab - Soft Tissue Sarcoma Adult, Angiosarcoma
Phase 2RecruitingNiels Junker802021-08-172023-07-27
Blood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Tissue Sarcomas
Blood and tissue collection for immunological studies, advanced imaging., neoadjuvant Therapy - Soft Tissue Sarcoma Adult
Not applicableActive not recruitingUniversity Hospital Tuebingen302021-07-212026-10-13
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
Retifanlimab, Gemcitabine, Docetaxel - Soft Tissue Sarcoma, Sarcoma,Soft Tissue
Phase 1 / Phase 2RecruitingMemorial Sloan Kettering Cancer Center982020-09-292026-09-08
Pre-operative RadiothErapy for Soft Tissue SarcOmas
Hypofractionation - Soft Tissue Sarcoma Adult
Not applicableActive not recruitingMcGill University Health Centre/Research Institute of the McGill University Health Centre152020-06-052025-06-25
Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study
Association of Nivolumab + Relatlimab, Nivolumab - Soft Tissue Sarcoma Adult, Advanced Cancer
Phase 2CompletedInstitut Bergonié682020-02-272026-04-21
Combined Treatment of Patients With Soft Tissue Sarcoma Including Preoperative Stereotactic Radiation Therapy and Postoperative Conformal Radiation Therapy
Preoperative stereotactic radiation therapy in hypofractionation mode, Surgery, Postoperative conformal radiation therapy in normofractionation mode - Soft Tissue Sarcoma Adult
Not applicableRecruitingN.N. Petrov National Medical Research Center of Oncology302020-02-012020-04-01
Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients
Trabectedin - Soft Tissue Sarcoma Adult, Undifferentiated Pleomorphic Sarcoma
Not applicableCompletedInstitut Bergonié292020-01-062026-03-06
Efficacy and Safety of Anlotinib in Adjuvant Therapy for High-grade Soft Tissue Sarcoma
Anlotinib Hydrochloride, Placebo Oral Tablet - Soft Tissue Sarcoma Adult, High Grade Sarcoma
Phase 2CompletedFudan University882019-05-132025-05-14
Study of a Cohort of Cases of Synovial Sarcoma Treated in the Orthopedic Surgery and Traumatology Department of the Hospital de Sant Pau Between 1983 and 2016
Soft tissue sarcomas in adults - Soft Tissue Sarcoma Adult
CompletedFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1022019-02-012020-02-24

Showing 20 of 27. Sign in to see all of them.

Narrower conditions

Sarcoma (16)  ·  Histiocytoma, Malignant Fibrous (5)  ·  Leiomyosarcoma (4)  ·  Liposarcoma (4)  ·  Sarcoma, Synovial (4)  ·  Dermatofibrosarcoma (2)  ·  Hemangiosarcoma (2)  ·  Squamous Cell Carcinoma of Head and Neck (2)  ·  Triple Negative Breast Neoplasms (2)  ·  Hemangioendothelioma (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)  ·  Osteosarcoma (1)  ·  Sarcoma, Ewing (1)  ·  Solitary Fibrous Tumors (1)

Broader conditions

Neoplasms by Histologic Type (19)  ·  Neoplasms (18)  ·  Neoplasms, Connective and Soft Tissue (17)  ·  Neoplasms, Connective Tissue (6)  ·  Histiocytoma (5)  ·  Neoplasms, Fibrous Tissue (5)  ·  Neoplasms, Adipose Tissue (4)  ·  Neoplasms, Muscle Tissue (4)  ·  Neoplasms, Vascular Tissue (3)  ·  Breast Diseases (2)  ·  Breast Neoplasms (2)  ·  Carcinoma (2)  ·  Carcinoma, Squamous Cell (2)  ·  Fibrosarcoma (2)  ·  Head and Neck Neoplasms (2)

Interventions

Docetaxel (2)  ·  Doxorubicin (2)  ·  Gemcitabine (2)  ·  Nivolumab (2)  ·  Trabectedin (2)  ·  eribulin (2)  ·  pembrolizumab (2)  ·  AZD1390 (1)  ·  Absorptiometry, Photon (1)  ·  Aminolevulinic Acid (1)  ·  Blood Specimen Collection (1)  ·  Bortezomib (1)  ·  Control Groups (1)  ·  Cyclophosphamide (1)  ·  Geriatric Assessment (1)

Sponsors

Institut Bergonié (4)  ·  Fudan University (2)  ·  Oslo University Hospital (2)  ·  Pure Biologics S.A. (2)  ·  Centre Oscar Lambret (1)  ·  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1)  ·  GWT-TUD GmbH (1)  ·  Istituto Oncologico Veneto IRCCS (1)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  N.N. Petrov National Medical Research Center of Oncology (1)  ·  National Taiwan University Hospital (1)  ·  Niels Junker (1)  ·  Peking University People's Hospital (1)  ·  Presage Biosciences (1)

Countries

United States (7)  ·  France (5)  ·  Norway (3)  ·  China (2)  ·  Germany (2)  ·  Canada (1)  ·  Denmark (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Russia (1)  ·  Spain (1)  ·  Sweden (1)  ·  Taiwan (1)  ·  United Kingdom (1)

Top investigators

Ivar Hompland, MD, PhD (2)  ·  Kjetil Boye, MD, PhD (2)  ·  Antonella Brunello (1)  ·  Claudia Lamas (1)  ·  Fabio Cury, MD (1)  ·  Gary Deutsch, MD (1)  ·  John Weinberg (1)  ·  John Weinberg, MBBCH (1)  ·  Kenneth Gundle, MD (1)  ·  Markus Schuler, Dr. (1)  ·  Niels Junker, MD, PhD (1)  ·  Richard Kenney, MD (1)  ·  Rick Haas, MD Prof (1)  ·  Robin Jones, MD (1)

Results publications

PMID 32299817, PMID 36129471, PMID 39918552

NIH funding

2019 (1)